The Latest Cardiac and Vascular News
New York, January 9, 2025: The world’s most adopted healthcare AI company, Qure.ai, has appointed a new Chief Commercial Officer to oversee and expand global sales and business development strategy. Based in New York, Jim Mercadante joins a growing commercial and operations team to consolidate growing momentum and orchestrate further […]
LONG BEACH, Calif., Jan. 9, 2025 /PRNewswire/ — Christina Rodriguez, M.D., has been named medical director of advanced cardiac imaging at MemorialCare Heart & Vascular Institute at Long Beach Medical Center. Dr. Rodriguez is a fellowship-trained, board-certified, non-invasive…
PLANO, Texas, Jan. 9, 2025 /PRNewswire/ — Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announced the first patient enrollment in the CLEAN-PE study. The prospective,…
Inexpensive wearable technology for diagnostics and monitoring has the power to transform cardiac care BRENTWOOD, Tenn., Jan. 9, 2025 /PRNewswire/ — Peerbridge Health has announced the launch of its landmark COR-INSIGHT Trial, which will validate the screening and diagnostic capabilities…
Including market leading Arrow™ CVCs and Arterial Catheters Including market leading Arrow™ CVCs and Arterial Catheters
New Brunswick, NJ, January 8, 2025 – At Johnson & Johnson MedTech, the health and safety of our patients is our top priority. On January 5, out of an abundance of caution, Johnson & Johnson MedTech temporarily paused the U.S. External Evaluation and all U.S. VARIPULSE™ cases while we investigate the root cause of four […]
orthStar to support the development of YAP Therapeutics’ innovative radiolabeled products This collaboration merges the expertise and resources from both companies, including NorthStar’s state-of-the-art facilities The agreement guarantees that YAP Therapeutics will receive clinical trial-ready doses of its novel products in development January 08, 2025 08:01 AM Eastern Standard Time […]
Over 90 patients have received the Aeson® artificial heart since the first implant in 2013, including 42 in 2024. 2024 Sales of €7 million (a 2.5-fold increase vs 2023). Cash burn reduced by over 20% vs 2023. 50 hospitals trained in Aeson® implants internationally1. Successful first “Aeson® User Meeting” and […]
EMERYVILLE, Calif.–(BUSINESS WIRE)–Fauna Bio, a biotechnology company improving human health by leveraging animal genomics, today announced Faun1083 as its first development candidate. Discovered through Fauna Bio’s proprietary Convergence™ drug discovery platform, Faun1083 is a potential first-in-class therapeutic targeting heart failure with preserved ejection fraction (HFpEF), a disease with currently limited […]
BURLINGTON, Mass.–(BUSINESS WIRE)–Cardurion Pharmaceuticals, Inc. (“Cardurion”), a clinical-stage biotechnology company discovering and developing new therapeutic approaches for the treatment of cardiovascular diseases, today announced that Charlotte (Charlie) Newman has joined the company as Chief Business Officer. A biopharmaceutical industry executive with over 25 years of industry experience, Ms. Newman most recently […]
